本页面由Tiger Trade Technology Pte. Ltd.提供服务

10x Genomics, Inc.

77.49
-3.1650-3.92%
成交量:46.78万
成交额:3,691.77万
市值:100.96亿
市盈率:-131.69
高:80.47
开:79.18
低:77.49
收:80.65
52周最高:102.81
52周最低:11.16
股本:1.30亿
流通股本:1.18亿
量比:0.49
换手率:0.40%
股息:- -
股息率:- -
每股收益(TTM):-0.5884
每股收益(LYR):-0.3490
净资产收益率:-9.40%
总资产收益率:-5.05%
市净率:12.23
市盈率(LYR):-221.99

数据加载中...

2026/10/07

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/09/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/08

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/09/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/07

重要事件披露

Form 8-K - Current report
2026/06/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/08

重要事件披露

Form 8-K - Current report
2026/05/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities